Date  |
|
| Jul 29, 2021 |
ReShape Lifesciences to Report Second Quarter 2021 Financial and Operational Results on Thursday, August 5, 2021 |
| Jul 13, 2021 |
ReShape Lifesciences(TM) Launches Online Consumer Marketplace Offering Products Supporting Four Key Dimensions of Wellness: Nutrition, Exercise, Sleep and Stress |
| Jul 7, 2021 |
ReShape Lifesciences Moves Lap-Band Manufacturing to United States |
| Jul 1, 2021 |
ReShape Lifesciences Sees Lap-Band Growth as COVID-19 Pandemic Heightens Obesity Crisis |
| Jun 30, 2021 |
ReShape Lifesciences Completes $46 Million Capital Raise With Key Institutional Shareholders |
| Jun 29, 2021 |
ReShape Lifesciences Enters into Warrant Exercise Transaction for $46.2 Million in Gross Proceeds |
| Jun 17, 2021 |
ReShape Lifesciences Closes First Day of Trading on the NASDAQ Capital Market |
| Jun 16, 2021 |
ReShape Lifesciences Completes Merger with Obalon Therapeutics |
| Jun 15, 2021 |
ReShape Lifesciences Inc. and Obalon Therapeutics, Inc. Announce Anticipated Closing of Merger |
| Jun 8, 2021 |
ReShape Lifesciences Inc. and Obalon Therapeutics, Inc. Update on Status of Pending Merger |